12th pharmacovigilance stakeholder forum

EventHumanRegulatory and procedural guidancePharmacovigilance

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date: Pirmdiena, 24 Septembris 2018, Visu dienu
Vieta: European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and the pharmaceutical industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Video

Documents

Agenda – 12th Pharmacovigilance stakeholder forum

Reference Number: EMA/274125/2018

English (EN) (75.95 KB - PDF)

Pirmo reizi publicēts: 19/09/2018 Pēdējo reizi atjaunināts: 02/10/2018

List of participants: 12th stakeholder forum on the pharmacovigilance legislation

Reference Number: EMA/505196/2018

English (EN) (83.22 KB - PDF)

Pirmo reizi publicēts: 05/10/2018

Presentation - Pharmacovigilance in 2018 (P. Arlett)

English (EN) (2.56 MB - PDF)

Pirmo reizi publicēts: 05/10/2018

Presentation - Overview of current patient involvement (M. Mavris)

English (EN) (1.15 MB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Public Hearings; experience so far (N. Bere)

English (EN) (318.9 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - The engagement of patients and healthcare professionals in regulatory pharmacovigilance: developing a conceptualisation (P. Brown)

English (EN) (1.18 MB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Valproate case study: industry perspective (E. Teo)

English (EN) (172.44 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Public hearing on valproate: Account of events and outcomes (E. Vatzaki)

English (EN) (181.97 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Valproate case study: patients' perspective (F.Houyez)

English (EN) (2.84 MB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Valproate case study: pharmacists' perspective (R. Anderson)

English (EN) (892.25 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Valproate case study: doctors' perspective (R. Kalvianen)

English (EN) (921.29 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Valproate case study: engagement of patients and healthcare professionals (P. Bahri)

English (EN) (245.16 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, doctors' vision (C. Matias)

English (EN) (730.35 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, pharmacists' vision (J. De Belie)

English (EN) (658.34 KB - PDF)

Pirmo reizi publicēts: 08/10/2018

Presentation - Pharmacovigilance in the next 5 years, industry vision (V. Edwards)

English (EN) (1.12 MB - PDF)

Pirmo reizi publicēts: 08/10/2018